Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6767254 | 0.84 | TSHR (0.37) | TSHRSLC22A6 | |
| SCHEMBL22064125 | 0.82 | ALDH1A1 (0.32) | ALDH1A1TP53MAPTHPGDHTT | |
| SCHEMBL4969197 | 0.81 | TSHR (0.33) | TSHR | |
| SCHEMBL208988 | 0.79 | TSHR (0.36) | TSHRALDH1A1 | |
| SCHEMBL23111823 | 0.79 | TSHR (0.35) | TSHR | |
| SCHEMBL7905682 | 0.79 | TSHR (0.37) | TSHR | |
| SCHEMBL30806937 | 0.79 | TSHR (0.33) | TSHR | |
| SCHEMBL4858440 | 0.76 | LMNA (0.31) | — | |
| SCHEMBL34382 | 0.76 | TSHR (0.44) | TSHRSLC22A6 | |
| SCHEMBL9443639 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10688216-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2020-06-23 | — | — | US | claimed |
| US-9878066-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2018-01-30 | — | — | US | claimed |
| US-20170049924-A1 | CROSSLINKED GELS COMPRISING POLYALKYLENEIMINES, AND THEIR USES AS MEDICAL DEVICES | HYPERBRANCH MEDICAL TECHNOLOGY, INC. | 2017-02-23 | — | — | US | claimed |
| US-11826485-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-20210275718-A1 | Crosslinked Gels Comprising Polyalkyleneimines, And Their Uses As Medical Devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. | 2021-09-09 | — | — | US | disclosed |
| US-11027043-B1 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2021-06-08 | — | — | US | disclosed |
| US-10688216-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2020-06-23 | — | — | US | disclosed |
| US-20190001018-A1 | CROSSLINKED GELS COMPRISING POLYALKYLENEIMINES, AND THEIR USES AS MEDICAL DEVICES | HYPERBRANCH MEDICAL TECHNOLOGY, INC. | 2019-01-03 | — | — | US | disclosed |
| US-9878066-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2018-01-30 | — | — | US | disclosed |
| US-20170049924-A1 | CROSSLINKED GELS COMPRISING POLYALKYLENEIMINES, AND THEIR USES AS MEDICAL DEVICES | HYPERBRANCH MEDICAL TECHNOLOGY, INC. | 2017-02-23 | — | — | US | disclosed |
| US-9393344-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2016-07-19 | — | — | US | disclosed |
| EP-1996243-B1 | CROSSLINKED GELS COMPRISING POLYALKYLENEIMINES, AND THEIR USES AS MEDICAL DEVICES | HYPERBRANCH MEDICAL TECHNOLOGY INC (US) | 2014-04-23 | — | — | EP | disclosed |
| EP-2178997-A2 | POLYMERIC MASKING MATERIALS FOR SPANNING WOUND SITES, AND METHODS OF USE THEREOF | Hyperbranch Medical Technology, Inc. (US) | 2010-04-28 | — | — | EP | disclosed |
| US-20100069927-A1 | Polymeric Masking Materials for Spanning Wound Sites, and Methods of Use Thereof | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2010-03-18 | — | — | US | disclosed |
| WO-2009015124-A2 | POLYMERIC MASKING MATERIALS FOR SPANNING WOUND SITES, AND METHODS OF USE THEREOF | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| US-20070196454-A1 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10688216-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | PLOD3, LIG3, PLOD2 | TSHR 4855/4885SLC22A6 4395/4885ALDH1A1 842/4885 |
| US-20210275718-A1 | Crosslinked Gels Comprising Polyalkyleneimines, And Their Uses As Medical Devices | PLOD3, LIG3, PLOD2 | TSHR 4855/4885SLC22A6 4395/4885ALDH1A1 842/4885 |
| US-11826485-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | PLOD3, LIG3, PLOD2 | TSHR 4855/4885SLC22A6 4395/4885ALDH1A1 842/4885 |
| US-20070196454-A1 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | PLOD3, PLOD2, PLOD1 | TSHR 4792/4885SLC22A6 4232/4885ALDH1A1 950/4885 |
| US-11027043-B1 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | PLOD3, PLOD2, PLOD1 | TSHR 4811/4885SLC22A6 4283/4885ALDH1A1 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.